Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
10.84
-0.07 (-0.64%)
Mar 9, 2026, 3:36 PM EDT - Market open
Rallybio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 0.67 | 0.64 | - | - | - | - | Upgrade
|
| Cost of Revenue | 39.03 | 39.51 | 53.54 | - | - | - | Upgrade
|
| Gross Profit | -38.36 | -38.87 | -53.54 | - | - | - | Upgrade
|
| Selling, General & Admin | 13.81 | 18.33 | 25.39 | 27.2 | 18.74 | 7.67 | Upgrade
|
| Research & Development | -18.9 | - | - | 40.69 | 26.91 | 17.63 | Upgrade
|
| Operating Expenses | -5.1 | 18.33 | 25.39 | 67.88 | 45.65 | 25.3 | Upgrade
|
| Operating Income | -33.26 | -57.2 | -78.93 | -67.88 | -45.65 | -25.3 | Upgrade
|
| Interest Expense | - | - | - | - | -0.01 | -0.05 | Upgrade
|
| Interest & Investment Income | 2.44 | 4.22 | 6.15 | 1.96 | 0.05 | 0.17 | Upgrade
|
| Earnings From Equity Investments | -1.3 | -2.24 | -2.04 | -1.08 | -1.51 | -1.52 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.74 | 0.74 | 0.26 | 0.34 | 0.1 | 0.24 | Upgrade
|
| EBT Excluding Unusual Items | -31.38 | -54.48 | -74.56 | -66.65 | -47.01 | -26.46 | Upgrade
|
| Merger & Restructuring Charges | -5 | -3.3 | - | - | - | - | Upgrade
|
| Pretax Income | -14.17 | -57.78 | -74.56 | -66.65 | -47.01 | -26.46 | Upgrade
|
| Income Tax Expense | - | - | - | - | - | -0.02 | Upgrade
|
| Net Income | -14.17 | -57.78 | -74.56 | -66.65 | -47.01 | -26.45 | Upgrade
|
| Net Income to Common | -14.17 | -57.78 | -74.56 | -66.65 | -47.01 | -26.45 | Upgrade
|
| Shares Outstanding (Basic) | 6 | 5 | 5 | 4 | 3 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 6 | 5 | 5 | 4 | 3 | 2 | Upgrade
|
| Shares Change (YoY) | 5.40% | 7.66% | 27.11% | 24.70% | 46.76% | 913.79% | Upgrade
|
| EPS (Basic) | -2.53 | -10.61 | -14.75 | -16.76 | -14.74 | -12.17 | Upgrade
|
| EPS (Diluted) | -2.53 | -10.61 | -14.75 | -16.76 | -14.74 | -12.17 | Upgrade
|
| Free Cash Flow | -35 | -49.28 | -60.28 | -57.34 | -45.87 | -22.18 | Upgrade
|
| Free Cash Flow Per Share | -6.24 | -9.05 | -11.92 | -14.41 | -14.38 | -10.20 | Upgrade
|
| Operating Margin | -4934.72% | -8993.08% | - | - | - | - | Upgrade
|
| Profit Margin | -2102.37% | -9084.12% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | -5192.28% | -7748.74% | - | - | - | - | Upgrade
|
| EBITDA | -33.14 | -57.07 | -78.78 | -67.72 | -45.54 | -25.24 | Upgrade
|
| D&A For EBITDA | 0.12 | 0.13 | 0.15 | 0.17 | 0.11 | 0.06 | Upgrade
|
| EBIT | -33.26 | -57.2 | -78.93 | -67.88 | -45.65 | -25.3 | Upgrade
|
| Revenue as Reported | 0.67 | 0.64 | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.